Osteologie 2018; 27(03): 182-184
DOI: 10.1055/s-0038-1673559
DVO-Newsletter/Der Osteologe DVO und Informationen der Gesellschaft
Georg Thieme Verlag KG Stuttgart · New York

Einsatz der PET bei primären Knochentumoren

Swen Hesse
1   Klinik und Poliklinik für Nuklearmedizin, Universitätsklinikum Leipzig
,
Henryk Barthel
1   Klinik und Poliklinik für Nuklearmedizin, Universitätsklinikum Leipzig
,
Osama Sabri
1   Klinik und Poliklinik für Nuklearmedizin, Universitätsklinikum Leipzig
,
Regine Kluge
1   Klinik und Poliklinik für Nuklearmedizin, Universitätsklinikum Leipzig
› Author Affiliations
Further Information

Publication History

Publication Date:
21 September 2018 (online)

 

 


#
  • Literatur

  • 1 Franzius C, Sciuk J, Daldrup-Link HE, Jürgens H, Schober O. FDG-PET for detection of osseous metastases from malignant primary bone tumours: comparison with bone scintigraphy. Eur J Nucl Med 2000; 27: 1305-1311.
  • 2 Hawkins DS, Conrad 3rd EU, Butrynski JE, Schuetze SM, Eary JF. [F-18]-fluorodeoxy-D-glucose-positron emission tomography response is associated with outcome for extremity osteosarcoma in children and young adults. Cancer 2009; 115: 3519-3525.
  • 3 Hawkins DS, Schuetze SM, Butrynski JE, Rajendran JG, Vernon CB, Conrad 3rd EU, Eary JF. [18F]Fluorodeoxyglucose positron emission tomography predicts outcome for Ewing sarcoma family of tumors. J Clin Oncol 2005; 23: 8828-8834.

  • Literatur

  • 1 Franzius C, Sciuk J, Daldrup-Link HE, Jürgens H, Schober O. FDG-PET for detection of osseous metastases from malignant primary bone tumours: comparison with bone scintigraphy. Eur J Nucl Med 2000; 27: 1305-1311.
  • 2 Hawkins DS, Conrad 3rd EU, Butrynski JE, Schuetze SM, Eary JF. [F-18]-fluorodeoxy-D-glucose-positron emission tomography response is associated with outcome for extremity osteosarcoma in children and young adults. Cancer 2009; 115: 3519-3525.
  • 3 Hawkins DS, Schuetze SM, Butrynski JE, Rajendran JG, Vernon CB, Conrad 3rd EU, Eary JF. [18F]Fluorodeoxyglucose positron emission tomography predicts outcome for Ewing sarcoma family of tumors. J Clin Oncol 2005; 23: 8828-8834.